PhRMA DTC Guideline Compliance Could Avert Plaintiff, DoJ Backlash – Troy
Executive Summary
Responding to warning and untitled letters from FDA's Division of Drug Marketing, Advertising & Communications could help to shield firms in the event of product liability suits, according to former FDA Chief Counsel Daniel Troy